On June 30, 2026, Anthropic revealed its intention to begin developing its own pharmaceuticals, marking a significant pivot from its core focus on artificial intelligence.
The company plans to leverage its expertise in AI to enhance drug development processes, potentially transforming how pharmaceuticals are created.
This strategic move highlights Anthropic's ambition to diversify its operations and explore new opportunities within the pharmaceutical industry.